These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38865917)

  • 21. A comparison of swallowing dysfunction in Becker muscular dystrophy and Duchenne muscular dystrophy.
    Yamada Y; Kawakami M; Wada A; Otsuka T; Muraoka K; Liu M
    Disabil Rehabil; 2018 Jun; 40(12):1421-1425. PubMed ID: 28288529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variables associated with upper extremity function in patients with Duchenne muscular dystrophy.
    Janssen MM; Hendriks JC; Geurts AC; de Groot IJ
    J Neurol; 2016 Sep; 263(9):1810-8. PubMed ID: 27314968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tongue pressure during swallowing is decreased in patients with Duchenne muscular dystrophy.
    Hamanaka-Kondoh S; Kondoh J; Tamine K; Hori K; Fujiwara S; Maeda Y; Matsumura T; Yasui K; Fujimura H; Sakoda S; Ono T
    Neuromuscul Disord; 2014 Jun; 24(6):474-81. PubMed ID: 24684858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal Dysfunction in Patients with Duchenne Muscular Dystrophy.
    Lo Cascio CM; Goetze O; Latshang TD; Bluemel S; Frauenfelder T; Bloch KE
    PLoS One; 2016; 11(10):e0163779. PubMed ID: 27736891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic modifiers of respiratory function in Duchenne muscular dystrophy.
    Bello L; D'Angelo G; Villa M; Fusto A; Vianello S; Merlo B; Sabbatini D; Barp A; Gandossini S; Magri F; Comi GP; Pedemonte M; Tacchetti P; Lanzillotta V; Trucco F; D'Amico A; Bertini E; Astrea G; Politano L; Masson R; Baranello G; Albamonte E; De Mattia E; Rao F; Sansone VA; Previtali S; Messina S; Vita GL; Berardinelli A; Mongini T; Pini A; Pane M; Mercuri E; Vianello A; Bruno C; Hoffman EP; Morgenroth L; Gordish-Dressman H; McDonald CM; ; Pegoraro E
    Ann Clin Transl Neurol; 2020 May; 7(5):786-798. PubMed ID: 32343055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death.
    Wahlgren L; Kroksmark AK; Lindblad A; Tulinius M; Sofou K
    J Neurol; 2024 Jul; 271(7):4300-4309. PubMed ID: 38630313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of growth in ambulatory males with Duchenne muscular dystrophy.
    West NA; Yang ML; Weitzenkamp DA; Andrews J; Meaney FJ; Oleszek J; Miller LA; Matthews D; DiGuiseppi C
    J Pediatr; 2013 Dec; 163(6):1759-1763.e1. PubMed ID: 24103921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
    Mah JK; Clemens PR; Guglieri M; Smith EC; Finkel RS; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; McDonald CM; Damsker JM; Schwartz BD; Mengle-Gaw LJ; Jackowski S; Stimpson G; Ridout DA; Ayyar-Gupta V; Baranello G; Manzur AY; Muntoni F; Gordish-Dressman H; Leinonen M; Ward LM; Hoffman EP; Dang UJ;
    JAMA Netw Open; 2022 Jan; 5(1):e2144178. PubMed ID: 35076703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation disorders in Duchenne muscular dystrophy? Results of a registry-based online survey.
    Schorling DC; Müller CK; Pechmann A; Borell S; Langer T; Thiele S; Walter MC; Zieger B; Kirschner J
    Acta Myol; 2020 Mar; 39(1):2-12. PubMed ID: 32607473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading.
    Landfeldt E; Aleman A; Abner S; Zhang R; Werner C; Tomazos I; Lochmüller H; Quinlivan RM
    J Neuromuscul Dis; 2024; 11(1):25-57. PubMed ID: 37980679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures.
    Henricson EK; Abresch RT; Cnaan A; Hu F; Duong T; Arrieta A; Han J; Escolar DM; Florence JM; Clemens PR; Hoffman EP; McDonald CM;
    Muscle Nerve; 2013 Jul; 48(1):55-67. PubMed ID: 23649481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Blood Pressure and Body Mass Index as Potential Modifiable Factors in The Progression of Myocardial Dysfunction in Duchenne Muscular Dystrophy.
    van de Velde NM; Roest AAW; van Zwet EW; Niks EH
    J Neuromuscul Dis; 2019; 6(1):65-73. PubMed ID: 30400104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of posterior spinal fusion on respiratory function in Duchenne muscular dystrophy.
    Alexander WM; Smith M; Freeman BJ; Sutherland LM; Kennedy JD; Cundy PJ
    Eur Spine J; 2013 Feb; 22(2):411-6. PubMed ID: 23179984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests.
    Miller NF; Alfano LN; Iammarino MA; Connolly AM; Moore-Clingenpeel M; Powers BR; Tsao CY; Waldrop MA; Flanigan KM; Mendell JR; Lowes LP
    Pediatr Neurol; 2020 Dec; 113():15-20. PubMed ID: 32979653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome of SARS-CoV-2 infection in 7 adults with Duchenne muscular dystrophy attending a specialist neuromuscular centre.
    Quinlivan R; Desikan M; Cruces F; Pietrusz A; Savvatis K
    Neuromuscul Disord; 2021 Jul; 31(7):603-606. PubMed ID: 34049779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures.
    Segura LG; Lorenz JD; Weingarten TN; Scavonetto F; Bojanić K; Selcen D; Sprung J
    Paediatr Anaesth; 2013 Sep; 23(9):855-64. PubMed ID: 23919455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C.
    Villa CR; Kaddourah A; Mathew J; Ryan TD; Wong BL; Goldstein SL; Jefferies JL
    Neuromuscul Disord; 2016 Oct; 26(10):637-642. PubMed ID: 27542440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Truncal fat distribution correlates with decreased vital capacity in Duchenne muscular dystrophy.
    Canapari CA; Barrowman N; Hoey L; Walker SW; Townsend E; Tseng BS; Katz SL
    Pediatr Pulmonol; 2015 Jan; 50(1):63-70. PubMed ID: 24644236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.